154 related articles for article (PubMed ID: 31377469)
1. Anticancer activity of "Trigno M", extract of Prunus spinosa drupes, against in vitro 3D and in vivo colon cancer models.
Condello M; Pellegrini E; Spugnini EP; Baldi A; Amadio B; Vincenzi B; Occhionero G; Delfine S; Mastrodonato F; Meschini S
Biomed Pharmacother; 2019 Oct; 118():109281. PubMed ID: 31377469
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic and Apoptotic Activities of Prunus spinosa Trigno Ecotype Extract on Human Cancer Cells.
Meschini S; Pellegrini E; Condello M; Occhionero G; Delfine S; Condello G; Mastrodonato F
Molecules; 2017 Sep; 22(9):. PubMed ID: 28930188
[TBL] [Abstract][Full Text] [Related]
3.
Condello M; Vona R; Meschini S
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555736
[TBL] [Abstract][Full Text] [Related]
4. Lemongrass Extract Possesses Potent Anticancer Activity Against Human Colon Cancers, Inhibits Tumorigenesis, Enhances Efficacy of FOLFOX, and Reduces Its Adverse Effects.
Ruvinov I; Nguyen C; Scaria B; Vegh C; Zaitoon O; Baskaran K; Mehaidli A; Nunes M; Pandey S
Integr Cancer Ther; 2019; 18():1534735419889150. PubMed ID: 31845598
[TBL] [Abstract][Full Text] [Related]
5. An Ethanol Extract of Hawaiian Turmeric: Extensive In Vitro Anticancer Activity Against Human Colon Cancer Cells.
Dimas K; Tsimplouli C; Houchen C; Pantazis P; Sakellaridis N; Tsangaris GT; Anastasiadou E; Ramanujam RP
Altern Ther Health Med; 2015; 21 Suppl 2():46-54. PubMed ID: 26308760
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic activity of the seaweed compound fucosterol, alone and in combination with 5-fluorouracil, in colon cells using 2D and 3D culturing.
Ramos AA; Almeida T; Lima B; Rocha E
J Toxicol Environ Health A; 2019; 82(9):537-549. PubMed ID: 31258008
[TBL] [Abstract][Full Text] [Related]
7. The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.
Na YS; Jung KA; Kim SM; Hong YS; Ryu MH; Jang SJ; Moon DH; Cho DH; Kim JC; Lee JS; Kim TW
Cancer Chemother Pharmacol; 2011 Aug; 68(2):389-98. PubMed ID: 21046105
[TBL] [Abstract][Full Text] [Related]
8. Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: Contrasting viability and growth inhibition in clinically relevant dose and repeated drug cycles.
Tidwell TR; Røsland G; Tronstad KJ; Søreide K; Hagland HR
Cancer Med; 2024 Jun; 13(11):e7318. PubMed ID: 38872378
[TBL] [Abstract][Full Text] [Related]
9. Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo.
Yamai H; Sawada N; Yoshida T; Seike J; Takizawa H; Kenzaki K; Miyoshi T; Kondo K; Bando Y; Ohnishi Y; Tangoku A
Int J Cancer; 2009 Aug; 125(4):952-60. PubMed ID: 19462449
[TBL] [Abstract][Full Text] [Related]
10. Role of Natural Antioxidant Products in Colorectal Cancer Disease: A Focus on a Natural Compound Derived from
Condello M; Meschini S
Cells; 2021 Nov; 10(12):. PubMed ID: 34943833
[TBL] [Abstract][Full Text] [Related]
11. The labdane diterpene sclareol (labd-14-ene-8, 13-diol) induces apoptosis in human tumor cell lines and suppression of tumor growth in vivo via a p53-independent mechanism of action.
Mahaira LG; Tsimplouli C; Sakellaridis N; Alevizopoulos K; Demetzos C; Han Z; Pantazis P; Dimas K
Eur J Pharmacol; 2011 Sep; 666(1-3):173-82. PubMed ID: 21620827
[TBL] [Abstract][Full Text] [Related]
12. Regorafenib as a potential adjuvant chemotherapy agent in disseminated small colon cancer: Drug selection outcome of a novel screening system using nanoimprinting 3-dimensional culture with HCT116-RFP cells.
Yoshii Y; Furukawa T; Aoyama H; Adachi N; Zhang MR; Wakizaka H; Fujibayashi Y; Saga T
Int J Oncol; 2016 Apr; 48(4):1477-84. PubMed ID: 26820693
[TBL] [Abstract][Full Text] [Related]
13. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
[TBL] [Abstract][Full Text] [Related]
14. A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model.
Kim J; Kim HY; Hong S; Shin S; Kim YA; Kim NS; Bang OS
Biomed Pharmacother; 2019 Aug; 116():108987. PubMed ID: 31112870
[TBL] [Abstract][Full Text] [Related]
15. The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo.
Tumber A; Collins LS; Petersen KD; Thougaard A; Christiansen SJ; Dejligbjerg M; Jensen PB; Sehested M; Ritchie JW
Cancer Chemother Pharmacol; 2007 Jul; 60(2):275-83. PubMed ID: 17124594
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of sequential treatment of HCT116 colon cancer monolayers and xenografts with docetaxel, flavopiridol, and 5-fluorouracil.
Guo J; Zhou AW; Fu YC; Verma UN; Tripathy D; Frenkel EP; Becerra CR
Acta Pharmacol Sin; 2006 Oct; 27(10):1375-81. PubMed ID: 17007746
[TBL] [Abstract][Full Text] [Related]
17. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
[TBL] [Abstract][Full Text] [Related]
18. In vitro anticancer activity of Eclipta alba whole plant extract on colon cancer cell HCT-116.
Nelson VK; Sahoo NK; Sahu M; Sudhan HH; Pullaiah CP; Muralikrishna KS
BMC Complement Med Ther; 2020 Nov; 20(1):355. PubMed ID: 33225921
[TBL] [Abstract][Full Text] [Related]
19. Antitumor Ability of KT2 Peptide Derived from Leukocyte Peptide of Crocodile Against Human HCT116 Colon Cancer Xenografts.
Maraming P; Maijaroen S; Klaynongsruang S; Boonsiri P; Daduang S; Chung JG; Daduang J
In Vivo; 2018; 32(5):1137-1144. PubMed ID: 30150436
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL.
Woo JK; Kang JH; Jang YS; Ro S; Cho JM; Kim HM; Lee SJ; Oh SH
Oncol Rep; 2015 Apr; 33(4):1947-55. PubMed ID: 25672292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
